BACKGROUND: Neurological Examination Abnormalities (NEA, often called "neurological soft signs") have been observed in early schizophrenia and may be heritable. We investigated the prevalence, and neurocognitive and psychopathological correlates of NEA among offspring of schizophrenia patients who are at increased genetic risk for this illness. METHODS: Neurological examinations were conducted on high risk (HR, n=74) and healthy comparison subjects (HS, n=86), using the Heinrichs-Buchanan scale. Cognitive-perceptual (CogPer) and repetitive motor (RepMot) subscores, and total NEA scores were computed. All HR and HS were assessed using K-SADS/SCID for diagnoses. Schizotypy was measured using the Magical Ideation and the Perceptual Aberration subscales (Chapman scale), attention using Continuous Performance Test (CPT-IP) and executive functions using the Wisconsin Card Sorting Test (WCST). RESULTS: CogPer (F(1,160)=7.14, p=0.008) but not RepMot NEA scores were higher in HR subjects compared to HS after controlling for age and sex. CogPer NEA scores were higher in HR subjects with axis I psychopathology compared to those without (F(2,170)-6.41, p=0.002). HR subjects had higher schizotypy scores (composite of the magical ideation and perceptual aberration scales) (F(1,141)=23.25, p=0.000004). Schizotypy scores were negatively correlated with sustained attention and executive functions. In addition, schizotypy was positively correlated with CogPer NEA scores. CONCLUSIONS: Young relatives at increased genetic risk for schizophrenia show more frequent NEA. CogPer but not RepMot NEA scores were elevated, consistent with our prior observation of CogPer NEA being relatively specific for schizophrenia. The observed relationships between NEA, cognitive impairments, schizotypy and axis I disorders suggest that NEA may characterize a subgroup of HR offspring at an elevated risk for psychopathology.
BACKGROUND:Neurological Examination Abnormalities (NEA, often called "neurological soft signs") have been observed in early schizophrenia and may be heritable. We investigated the prevalence, and neurocognitive and psychopathological correlates of NEA among offspring of schizophreniapatients who are at increased genetic risk for this illness. METHODS: Neurological examinations were conducted on high risk (HR, n=74) and healthy comparison subjects (HS, n=86), using the Heinrichs-Buchanan scale. Cognitive-perceptual (CogPer) and repetitive motor (RepMot) subscores, and total NEA scores were computed. All HR and HS were assessed using K-SADS/SCID for diagnoses. Schizotypy was measured using the Magical Ideation and the Perceptual Aberration subscales (Chapman scale), attention using Continuous Performance Test (CPT-IP) and executive functions using the Wisconsin Card Sorting Test (WCST). RESULTS: CogPer (F(1,160)=7.14, p=0.008) but not RepMot NEA scores were higher in HR subjects compared to HS after controlling for age and sex. CogPer NEA scores were higher in HR subjects with axis I psychopathology compared to those without (F(2,170)-6.41, p=0.002). HR subjects had higher schizotypy scores (composite of the magical ideation and perceptual aberration scales) (F(1,141)=23.25, p=0.000004). Schizotypy scores were negatively correlated with sustained attention and executive functions. In addition, schizotypy was positively correlated with CogPer NEA scores. CONCLUSIONS: Young relatives at increased genetic risk for schizophrenia show more frequent NEA. CogPer but not RepMot NEA scores were elevated, consistent with our prior observation of CogPer NEA being relatively specific for schizophrenia. The observed relationships between NEA, cognitive impairments, schizotypy and axis I disorders suggest that NEA may characterize a subgroup of HR offspring at an elevated risk for psychopathology.
Authors: Richard D Sanders; Daniel Schuepbach; Gerald Goldstein; Gretchen L Haas; John A Sweeney; Matcheri S Keshavan Journal: J Neuropsychiatry Clin Neurosci Date: 2004 Impact factor: 2.198
Authors: Raquel E Gur; Vishwajit L Nimgaonkar; Laura Almasy; Monica E Calkins; J Daniel Ragland; Michael F Pogue-Geile; Stephen Kanes; John Blangero; Ruben C Gur Journal: Am J Psychiatry Date: 2007-05 Impact factor: 18.112
Authors: R D Sanders; S D Forman; J N Pierri; R W Baker; M E Kelley; D P Van Kammen; M S Keshavan Journal: Schizophr Res Date: 1998-02-09 Impact factor: 4.939
Authors: R D Sanders; M S Keshavan; S D Forman; J N Pieri; N McLaughlin; D N Allen; D P van Kammen; G Goldstein Journal: Psychiatry Res Date: 2000-09-11 Impact factor: 3.222
Authors: Franck Schürhoff; Andrei Szöke; Fabien Chevalier; Isabelle Roy; Alexandre Méary; Frank Bellivier; Bruno Giros; Marion Leboyer Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-01-05 Impact factor: 3.568
Authors: William P Horan; Steven P Reise; Kenneth L Subotnik; Joseph Ventura; Keith H Nuechterlein Journal: Schizophr Res Date: 2008-01-24 Impact factor: 4.939
Authors: Paulo L Lizano; Jeffrey K Yao; Neeraj Tandon; Suraj Sarvode Mothi; Debra M Montrose; Matcheri S Keshavan Journal: Schizophr Res Date: 2016-11-15 Impact factor: 4.939
Authors: Victor Peralta; Lucía Moreno-Izco; Ana Sanchez-Torres; Elena García de Jalón; Maria S Campos; Manuel J Cuesta Journal: Schizophr Bull Date: 2012-12-18 Impact factor: 9.306
Authors: Benjamin K Brent; Larry J Seidman; Heidi W Thermenos; Daphne J Holt; Matcheri S Keshavan Journal: Schizophr Res Date: 2013-08-06 Impact factor: 4.939
Authors: Ann K Shinn; Justin T Baker; Kathryn E Lewandowski; Dost Öngür; Bruce M Cohen Journal: Front Hum Neurosci Date: 2015-03-18 Impact factor: 3.169
Authors: Saskia de Leede-Smith; Steven Roodenrys; Lauren Horsley; Shannen Matrini; Erin Mison; Emma Barkus Journal: Schizophr Res Cogn Date: 2016-12-23
Authors: Igor Elman; Tamara V Gurvits; Evelyne Tschibelu; Justin D Spring; Natasha B Lasko; Roger K Pitman Journal: PLoS One Date: 2013-04-04 Impact factor: 3.240